Success Metrics

Clinical Success Rate
83.3%

Based on 10 completed trials

Completion Rate
83%(10/12)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(17%)

Phase Distribution

Ph phase_3
4
33%
Ph not_applicable
2
17%
Ph phase_4
2
17%
Ph phase_2
4
33%

Phase Distribution

0

Early Stage

4

Mid Stage

6

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
4(33.3%)
Phase 3Large-scale testing
4(33.3%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
2(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(10)
Terminated(2)

Detailed Status

Completed10
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (33.3%)
Phase 34 (33.3%)
Phase 42 (16.7%)
N/A2 (16.7%)

Trials by Status

completed1083%
terminated217%

Recent Activity

0 active trials
Showing 5 of 12
completedphase_2

Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC

NCT00385606
terminatedphase_4

A Double-blind, Double-dummy, Multicenter, Randomized Study of the Efficacy and Tolerability of Valdecoxib 40 mg Versus Rofecoxib 50 mg in Treating the Symptoms of Ankle Sprain

NCT00657449
completedphase_3

Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)

NCT00060476
completedphase_3

Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer

NCT00031863
completednot_applicable

CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen

NCT01762891
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT00385606Phase 2

Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC

Completed
NCT00657449Phase 4

A Double-blind, Double-dummy, Multicenter, Randomized Study of the Efficacy and Tolerability of Valdecoxib 40 mg Versus Rofecoxib 50 mg in Treating the Symptoms of Ankle Sprain

Terminated
NCT00060476Phase 3

Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)

Completed
NCT00031863Phase 3

Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer

Completed
NCT01762891Not Applicable

CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen

Completed
NCT00568295Phase 3

A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee

Completed
NCT00844727Phase 2

Coxib-inhibition of Duodenal Polyp Growth in FAP

Terminated
NCT00637988Phase 4

Barrett's Esophagus - 315 - 3 Way Cross Over

Completed
NCT00004845Phase 2

A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)

Completed
NCT00637949Phase 3

Safety of Lumiracoxib in Patients With Osteoarthritis

Completed
NCT00026819Phase 2

Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction

Completed
NCT00263094Not Applicable

An End to the Yom Kippur (and Ramadan) Headache

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12